Clinical outcomes after lung transplantation for fibrosis in telomerase related genes mutation carriers - Aix-Marseille Université Access content directly
Conference Papers Year : 2019

Clinical outcomes after lung transplantation for fibrosis in telomerase related genes mutation carriers

Mathilde Phillips Houlbracq
  • Function : Author
Antoine Roux
  • Function : Author
Sylvain Marchand-Adam
  • Function : Author
  • PersonId : 989455
Romain Lazor
  • Function : Author
  • PersonId : 1041305
Aurélie Le Borgne
  • Function : Author

Abstract

Carriers of telomerase related genes (TRG) mutation seem to present a worst prognosis with more common hematological complications after lung transplantation (LT) for pulmonary fibrosis. The aim of this study was to describe the outcomes after LT and identify pre-LT prognosis factors in a multicenter cohort of lung transplant recipients with TRG mutation. We retrospectively reviewed all identified patients with pathogenic TRG mutation (n=38; TERT, n=22, TERC, n=10, RTEL1, n=6) who received LT in France, Switzerland and Belgium between 2009 and 2018. The median age at LT was 54 years (46-59), 70% were male, and 60% had idiopathic pulmonary fibrosis (IPF). At diagnosis of pulmonary fibrosis, 84% had a hematological disease, including 8 with myelodysplasia, and 45% had a liver disease. After a median follow up of 2.2 years (1,2-3,7), 16 received a single LT, 22 a double LT and 2 a combined liver-LT. The overall post-LT median survival was 3.75 years (1.8-NA). Patients with myelodysplasia before LT had an increased risk of death after LT (HR= 4.12 (1.47-11.53) p=0.007). After LT, all patients showed anemia, 70% thrombocytopenia, and 60% neutropenia. Four patients showed severe liver disease: portal hypertension, cirrhosis. Sixteen patients (42%) experienced acute renal failure and 18 (47%) developed chronic renal insufficiency during follow up. Four developed chronic lung allograft dysfunction. Overall survival after LT supports LT in TRG mutation carriers. Careful evaluation at diagnosis, might limit LT indication for patients with established myelodysplasia.
No file

Dates and versions

hal-02546160 , version 1 (17-04-2020)

Identifiers

Cite

Mathilde Phillips Houlbracq, Hervé Mal, Vincent Cottin, Francois Philit, Sandrine Hirschi, et al.. Clinical outcomes after lung transplantation for fibrosis in telomerase related genes mutation carriers. European-Respiratory-Society (ERS) International Congress, Sep 2019, madrid, Spain. pp.PA3365, ⟨10.1183/13993003.congress-2019.PA3365⟩. ⟨hal-02546160⟩
111 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More